GSK Pharma to invest Rs.1,000 cr in tablets, capsules unit near Bengaluru

GlaxoSmithKline Pharmaceuti­cals Ltd (GSK) has decided to in­vest Rs. l,000 crore to set up facility to manufacture tablets and capsules.

The Karnataka government has allotted 50 acres of KIADB land at Vemgal Industrial Area in Kolar for the purpose. The facility is ex­pected to generate jobs for 232.

Ian Felton, Deputy High Com­missioner, British Deputy High Commission, Bengaluru, said the tentative date for the ground breaking ceremony of the GSK fa-cility is likely to be September 8. He extended formal invitation to the Karnataka Chief Minister Sid-daramaiah, and RV Deshpande, Karnataka Minister for Large & Medium Industries and Tourism today.

The global pharmaceutical company's facility at Vemgal, Ko­lar, is the first new manufactur­ing facility of the company after a gap of 15 years anywhere in the world, said Felton.

GSK has its presence in India since 1924, and currently employs over 4,500 people. The company two manufacturing units in Na-sik and Thane as well as a clinical development centre in Bengalu­ru.

A business delegation of UK businessmen led by Richard Heald, CEO, UK India Business Council (UKBC) called on K Ratna Prabha, Karnataka Additional Chief Secretary to Commerce and Industries Department and BS Shekarappa, CEO and EM, KIADB and discussed about GlaxoSmith­Kline Pharmaceuticals invest­ments in Karnataka.

The UKBC team invited the Kar­nataka government to participa-. te in 'India UK Business Conven-tion 2015' scheduled to be held at New Delhi from September 10 to 12.

Ratna Prabha said Karnataka Minister for Large and Medium Industries Deshpande is likely to address the largest gathering of UK businesses in India about the opportunities in Karnataka on September 11 in the plenary ses­sion entitled 'Competitive Federalism'.

"This will be a great opportuni­ty to attract top UK companies to Karnataka during Invest Karnata­ka 2015 scheduled during Novem­ber 23-25," she added.